Covid-19: Serum Institute says to meet local demand for Oxford vaccine for next 2 months, before exporting

By: |
January 3, 2021 8:46 PM

Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.

Serum-Oxford covid vaccineSII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.

Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India’s own immediate demand in the next two months before exporting to other interested countries.

Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world’s second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.

The Indian government just wants to ensure that “the most vulnerable people of the country get it first – I fully endorse and support that decision”, he said.

SII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccination in India: Over 23 lakh healthcare workers immunized so far across country, says health ministry
2Covid-19: China administers vaccines to 22.77 million people ahead of Chinese New Year holidays
3Coronavirus: Pakistan unveils plan to administer Covid-19 vaccine across country